Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Goodwill & Intangibles (2016 - 2025)

Ascendis Pharma A's Goodwill & Intangibles history spans 8 years, with the latest figure at -$1.5 million for Q4 2023.

  • For Q4 2023, Goodwill & Intangibles fell 129.97% year-over-year to -$1.5 million; the TTM value through Dec 2023 reached -$1.5 million, down 129.97%, while the annual FY2023 figure was -$1.5 million, 129.17% down from the prior year.
  • Goodwill & Intangibles for Q4 2023 was -$1.5 million at Ascendis Pharma A, down from $4.9 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $6.8 million in Q4 2020 and bottomed at -$1.5 million in Q4 2023.
  • The 5-year median for Goodwill & Intangibles is $4.9 million (2022), against an average of $4.0 million.
  • The largest annual shift saw Goodwill & Intangibles surged 76.2% in 2020 before it tumbled 129.97% in 2023.
  • A 5-year view of Goodwill & Intangibles shows it stood at $3.9 million in 2019, then soared by 76.2% to $6.8 million in 2020, then fell by 11.52% to $6.0 million in 2021, then dropped by 18.33% to $4.9 million in 2022, then crashed by 129.97% to -$1.5 million in 2023.
  • Per Business Quant, the three most recent readings for ASND's Goodwill & Intangibles are -$1.5 million (Q4 2023), $4.9 million (Q4 2022), and $6.0 million (Q4 2021).